Biological
CHAD63 clinical trials
- studies test it
- 12
- open now
- 1
- in phase 3
- 0
- first study started
- 2011
Keep track of what changes. Save the CHAD63 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
University of Oxford (9) · University of York (2) · University Hospital Tuebingen (1)
Often tested with
Tested in the same studies.
MVA me-trap (4) · Pyronaridine tetraphosphate, artesunate drug combination (1) · PfSPZ Challenge (1)
Studies
Open first, then newest update. How each study uses CHAD63 is read from its arms, and is right about nine times in ten.
Testing it · 12
- Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in AdultsNot yet recruitingPhase 1/2University Hospital TuebingenNCT05441410Written as ChAd63 ME-TRAP
- A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDLCompletedPhase 2University of YorkNCT03969134Written as ChAd63-KH
- A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of AdministrationCompletedPhase 1University of OxfordNCT03084289Written as ChAd63-METRAP
- A Study of a New Leishmania Vaccine Candidate ChAd63-KHCompletedPhase 2University of YorkNCT02894008Written as ChAd63-KH
- Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in TanzaniaCompletedPhase 1University of OxfordNCT03435874Written as ChAd63 RH5
- A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAPCompletedPhase 1/2University of OxfordNCT02905019Written as ChAd63 ME-TRAP
- Phase Ia Study of ChAd63/MVA PvDBPCompletedPhase 1University of OxfordNCT01816113Written as ChAd63 PvDBP 5 x 10^9
- A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,SCompletedPhase 1/2University of OxfordNCT02252640Written as ChAd63 ME-TRAP (5 x 10^10 vp)
- A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5CompletedPhase 1University of OxfordNCT02181088Written as ChAd63 RH5 low dose
- A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine CandidatesCompletedPhase 1/2University of OxfordNCT01623557Written as ChAd63-MVA CS
- A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,SCompletedPhase 1/2University of OxfordNCT01883609Written as ChAd63 ME-TRAP
- Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CSCompletedPhase 1University of OxfordNCT01450280Written as ChAd63 CS